Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Inaba

Showing results (11-20 of 430) with videos related to

Pageof 43
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Alendronate in the treatment of osteoporosis]Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Primary hyperparathyroidism]Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[New assay for parathyroid hormone]Masaaki Inaba
Clinical Calcium|January 7, 2006
[Bone metabolic marker; recent progress]Masaaki Inaba
Clinical Calcium|March 1, 2014
[Prediction by early change of bone metabolic markers of the efficacy of anti-osteoporotic drugs on bone mass in osteoporotic patients]Masaaki Inaba
Clinical Calcium|January 6, 2005
[Ibandronate as a new therapeutic agent for osteoporosis]Hitoshi Goto, Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Carboxyl-terminal propeptide of type I collagen(PICP)]Masaaki Inaba, Misako Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Diabetic osteoporosis]Yasuro Kumeda, Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2006
[Secondary hyperparathyroidism]Yasuo Imanishi, Masaaki Inaba
Clinical Calcium|September 1, 2015
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". CKD and osteoporosis]Shinsuke Yamada, Masaaki Inaba
Pageof 43

Showing results (11-20 of 430) with videos related to

Sort By:
Pageof 43
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Alendronate in the treatment of osteoporosis]Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Primary hyperparathyroidism]Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[New assay for parathyroid hormone]Masaaki Inaba
Clinical Calcium|January 7, 2006
[Bone metabolic marker; recent progress]Masaaki Inaba
Clinical Calcium|March 1, 2014
[Prediction by early change of bone metabolic markers of the efficacy of anti-osteoporotic drugs on bone mass in osteoporotic patients]Masaaki Inaba
Clinical Calcium|January 6, 2005
[Ibandronate as a new therapeutic agent for osteoporosis]Hitoshi Goto, Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Carboxyl-terminal propeptide of type I collagen(PICP)]Masaaki Inaba, Misako Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Diabetic osteoporosis]Yasuro Kumeda, Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2006
[Secondary hyperparathyroidism]Yasuo Imanishi, Masaaki Inaba
Clinical Calcium|September 1, 2015
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". CKD and osteoporosis]Shinsuke Yamada, Masaaki Inaba
Pageof 43